Introduction
Tissue and organ loss represents the final common fault of virtually all non-mental diseases including trauma, tumor resection, infections, and congenital anomalies. Tissue and organ shortage is a severe challenge worldwide.Reference Derby1,Reference Badylak, Weiss, Caplan and Macchiarini2 Each day, patients on various organ recipient waiting lists die before suitable donor organs become available. With aging populations, organ shortage is anticipated to exacerbate. One of the most promising features of tissue engineering (TE) and regenerative medicine is the possibility to generate organ scaffolds that may reduce or eliminate the need for donor organs.
Three-dimensional (3D) bioprinting, also called biofabrication, additive fabrication, or rapid prototyping, was developed in the early 1990s. Reference Cima, Sachs, Fan, Bredt, Michaels and Khanuja3 It is defined as a set of techniques using computer-aided printing methods to deposit living cells, biomaterials, extracellular matrix (ECM) components, biochemical factors, proteins, or drugs on a receiving solid or gel substrate or liquid reservoir.Reference Xu, Celli, Rizvi, Moon, Hasan and Demirci4 Recently, there has been growing interest in the application of bioprinting in TE due to its potential to create high throughput and efficient, scalable organ scaffolds.Reference Xu, Celli, Rizvi, Moon, Hasan and Demirci4,Reference Wang, Yan and Zhang5 A number of rapid prototyping technologies have been developed for tissue and organ printing, each with distinct advantages and disadvantages, including inkjet printing,Reference Layani, Darmawan, Foo, Liu, Kamyshny, Mandler, Magdassi and Lee6 laser-assisted bioprinting,Reference Guillotin, Souquet, Catros, Duocastella, Pippenger, Bellance, Bareille, Remy, Bordenave, Amedee and Guillemot7 valve-based droplet ejection printing,Reference Demirci and Montesano8,Reference Song, Adler, Xu, Kayaalp, Nureddin, Anchan, Maas and Demirci9 selective laser sintering,Reference Liu, Zhuang, Shuai and Peng10 stereolithography,Reference Pan, Zheng, Liu, Jing, Yong, Liang and Bing11 and fused deposition modelling.Reference Mironov, Boland, Trusk, Forgacs and Markwald12 Three-dimensional printing approaches share certain commonalities: (1) preprocessing to develop blueprints or computer-aided design by surface laser scan, computer tomography, magnetic resonance, or other imaging modalities; (2) processing to produce a physical 3D replica of a designed model; and (3) post-processing to improve organ maturation and further transplantationReference Mironov, Boland, Trusk, Forgacs and Markwald12 (Figure 1).
Schematics of three-dimensional (3D) bioprinting for tissue and organ regeneration. (a) Fabrication of 3D anatomical-shaped scaffolds with or without cell printing and/or deposition of molecular signaling cues. (b) In vitro culture of bioprinted scaffolds with cells. (c) In vivo implantation of 3D-bioprinted scaffolds. (d) Integration with native tissue and regeneration. Tissues represented are the lungs, liver, heart, kidney, blood vessels, tooth, skin, bone, joint, and ear. ★Images reprinted with permission from Reference 77. © 2014 Genetic Engineering and Biotechnology News. ◆Images reprinted with permission from Reference 78. © 2014 Columbia University Medical Center. ▲Image reprinted with permission from Reference 79. © 2014 Beckman Institute, University of Illinois at Urbana-Champaign.
In contrast to rapid development of 3D bioprinting techniques, there have been few studies utilizing 3D-printed scaffolds in preclinical models and even fewer have been utilized in patients or in patient clinical trials. In vitro 3D printing has created multiple tissue/organ scaffolds such as bone, cartilage, skin, nerve, and complex organs like teeth, nose, ears, heart, and liver.Reference Seol, Kang, Lee, Atala and Yoo13–Reference Pashuck and Stevens15 What is causing this dichotomy between robust development of 3D bioprinting techniques and the paucity of translation into preclinical or clinical studies? Following a comprehensive review, we attribute this paucity of translating 3D printing techniques from bench to bedside to a number of factors. Few biomaterial scientists and engineers have partnered with surgeons or scientists who are capable of performing preclinical and/or clinical studies. Technical factors that have precluded the application of 3D printing techniques in preclinical and/or clinical studies include cell survival and directed differentiation requirements, the fidelity of operating steps, as well as insufficient rate of vascularization, and diffusion of metabolites.
To date, translational studies from bench to the bedside have taken place primarily in bone, cartilage, teeth, and skin regeneration. Few preclinical studies have been conducted for the regeneration of internal organs such as the lungs, kidneys, liver, and heart. Here, we review 3D bioprinting with emphasis on preclinical studies and identify barriers toward translation into therapeutics.
Bioprinting in preclinical research
Bone regeneration by 3D-printed scaffolds
Bone grafting is currently used to treat large bone defects, but with limitations, which include graft availability, infections, donor site morbidity, and additional operative time and cost.Reference Castilho, Dias, Vorndran, Gbureck, Fernandes, Pires, Gouveia, Armes, Pires and Rodrigues16 Bioprinted bone graft materials will have a significant advantage as long as they show equivalency or compare favorably to current bone grafts. Ideally, 3D-printed bone grafts should be easy to handle, osteoinductive (spontaneous induction of bone formation) or at least osteoconductive (provision of an environment for bone formation but lacking spontaneous osteogenesis ability), promote mineralization and vascularization, and certainly be biocompatible.Reference Fedorovich, Alblas, Hennink, Oner and Dhert17,Reference Tamimi, Torres, Al-Abedalla, Lopez-Cabarcos, Alkhraisat, Bassett, Gbureck and Barralet18 In vivo studies for 3D printing for bone regeneration are summarized in Table I.
Three-dimensional printing for bone regeneration: in vivo studies.
Note: PCL, poly(caprolactone); PLGA, polylactic acid and polyglycolic acid; β-TCP, beta tricalcium phosphate; hASCs, human adipose stem cells; subQ, subcutaneous; rhBMP-2, recombinant human BMP-2; MSC, mesenchymal stem cell; MC3T3-E1, cell line derived from mice; TCP, tricalcium phosphate; BCP, biphasic calcium phosphate; HA, hydroxyapatite.
Delivery of osteogenic factors in 3D-printed scaffolds
Osteoinductive cues are pivotal for bone regeneration. Many growth factors (i.e., proteins and/or peptides that promote cell growth and tissue healing) such as vascular endothelial growth factor (VEGF), fibroblast growth factors, bone morphogenetic proteins (BMPs), parathyroid hormone, and platelet-derived growth factor have been used in bone TE. Delivery of growth factors in 3D-printed bone scaffolds can be enabled during or after the printing process. Several current printing technologies allow the deposition of proteins and peptides during printing.Reference Lee, Kang, Lee, Kim, Lee and Cho19
Alternatively, osteogenic factors can be delivered in previously printed scaffolds, either on the surface or within micropores/channels. Osteogenic factors are typically aimed toward enhanced cell recruitment, proliferation and differentiation, and angiogenesis.Reference Fedorovich, Alblas, Hennink, Oner and Dhert17 In a 3D-printed BMP-2-loaded model to repair critical rabbit segmental bone defects, sustained release of BMP-2 accelerated new bone formation without significant inflammatory response, whereas burst released (rapid release of large dose) BMP-2 failed to repair bone defects due to inflammatory response, with burst release defined as rapid unloading of encapsulated factors.Reference Shim, Kim, Park, Kundu, Kim, Kang and Cho20,Reference Poldervaart, Wang, van der Stok, Weinans, Leeuwenburgh, Oner, Dhert and Alblas21 Timely vascularization is essential for bone regeneration. Control released (sustained release over time) VEGF in 3D-printed scaffolds led to a significant increase in vessel formation after subcutaneous implantation (underneath the skin) in nude mice for one week, indicating that prolonged release of VEGF promotes vascularization.Reference Poldervaart, Gremmels, van Deventer, Fledderus, Oner, Verhaar, Dhert and Alblas22
Development of osteoinductive 3D scaffolds
Osteoinductive materials are highly desirable for bone regeneration. One of the difficulties in demonstrating osteoinductivity versus osteoconductivity is that these two terms polarize a continuum of osteogenesis. BMP-2 clearly is osteoinductive. However, few biomaterials can achieve the same level of osteoinductivity as BMP-2. Nonetheless, several 3D-printed biomaterials have shown substantial promise for various levels of osteoinductivity. Three-dimensional-printed hydroxyapatite (HA) and tricalcium phosphate (TCP) ceramic scaffolds by projection-based microstereolithography have been shown to improve bone regeneration by accelerated release of calcium ions.Reference Seol, Park, Jung, Jang, Girdhari, Kim and Cho23
The osteoinductive properties of printed scaffolds can also be enhanced by altering printing material ingredients. The combination of SiO2 and ZnO dopants in 3D-printed β-TCP scaffolds increased the capacity for early bone formation and neovascularization in bicortical (penetrating the opposite bone cortices) femur defects in a murine model for up to 16 weeks. Neovascularization was found to be up to three times higher in combination of SiO2 and ZnO dopants in TCP compared to TCP alone.Reference Fielding and Bose24 Mechanical interlocking between the implant and host tissue was stronger than the force it took to fracture the bone after four weeks.Reference Fielding and Bose24 Similarly, the addition of SrO and MgO in 3D-printed TCP scaffolds with multiscale porosity also contributed to early healing through accelerated osteogenesis in a rat distal femoral defect model.Reference Tarafder, Davies, Bandyopadhyay and Bose25
Scaffolds used for bioprinting can be modified to improve the characteristics of osteoconductivity and osseointegration. Enlargement of surface area via incorporation of nanostructured pores in 3D-printed poly-ε-caprolactone (PCL) scaffolds embedded with nanoporous PCL into a fusion-deposition model processes a thermoplastic filament to a semi-liquid state and extrudes the material across computer-controlled paths to build a given anatomic structure layer-upon-layer. This fusion-deposition model improved its osteogenic potential in repairing calvarial defects (bony defect in skull bones) in pigs.Reference Jensen, Rolfing, Svend Le, Kristiansen, Nygaard, Hokland, Bendtsen, Kassem, Lysdahl and Bunger26 Biodegradation of 3D scaffolds also influences in vivo bone formation by cell-material interactions. Rapidly degradable poly(hydroxymethylglycolide-co-ε-caprolactone) scaffolds obtained by fiber deposition (melt-plotting) showed biocompatibility to the extent of tissue-scaffold interactions and vascularization after four and 12 weeks following subcutaneous implantation in mice.Reference Seyednejad, Gawlitta, Kuiper, de Bruin, van Nostrum, Vermonden, Dhert and Hennink27
A scaffold’s internal architecture can influence the outcome of bone regeneration. Porosity characteristics such as pore size, volume fraction, percentage porosity, and pore shape are all important for cell adhesion, viability, and metabolism in scaffolds.Reference Sicchieri, Crippa, de Oliveira, Beloti and Rosa28 A major concern regarding porous scaffolds is the compromise in mechanical strength. By introducing microwave sintering, the mechanical strength of 3D-printed β-TCP scaffolds is enhanced to facilitate osteogenesis in repairing femoral defects in rats.Reference Tarafder, Balla and Davies29 Higher compressive strength was obtained when calcium phosphate powder was blended with a 3D-printed calcium sulfate (CaSO4)-based powder.Reference Zhou, Buchanan, Mitchell and Dunne30 Critical size murine femoral defects (defects of certain size beyond which self-repair is not possible) were repaired by optimization of material parameters for 3D-printed calcium phosphate scaffolds, and enhanced material properties were obtained by volumetric collagen incorporation via inkjet printing.Reference Inzana, Olvera, Fuller, Kelly, Graeve, Schwarz, Kates and Awad31
Cell delivery in bioprinted bone scaffolds
Currently, the common belief is that critical size bone defects cannot heal without cell delivery.Reference Mao, Stosich, Moioli, Lee, Fu, Bastian, Eisig, Zemnick, Ascherman, Wu, Rohde and Ahn32 Anatomically shaped PCL scaffolds with varying internal porosities were used to support the induction of human adipose-derived stem cells to form vascularized bone to repair mandibular and maxillary bone defects.Reference Temple, Hutton, Hung, Huri, Cook, Kondragunta, Jia and Grayson33 When 3D-printed highly porous biphasic calcium phosphate bone implants were ectopically implanted (i.e., in a location that is not anatomically the same) in the back of rats, osteogenic cells tended to induce bone formation mainly in the central region of the scaffolds. A combination of osteoblasts and BMP-2 synergistically yielded better bone formation by histomorphometric analysis (volumetric analysis on sections for microscopic structure studies of tissue).Reference Strobel, Rath, Maier, Beier, Arkudas, Greil, Horch and Kneser34 Spatially organized, functional osteogenic and endothelial progenitor cells (cells that form blood vessel lining) in printed grafts were observed after porous constructs containing the two cells were printed and subcutaneously implanted in immunodeficient mice.Reference Fedorovich, Wijnberg, Dhert and Alblas35 CD117+ hBMSCs (stem cell growth factor receptor and human bone marrow mesenchymal stem cells) were dispersed in different hydrogel mixtures and applied in a 3D-printed β-TCP/PLGA (tricalcium phosphate/poly(lactic-co-glycolic acid) scaffold.Reference Weinand, Gupta, Weinberg, Madisch, Neville, Jupiter and Vacanti36 Constructs were implanted subcutaneously into nude mice for six weeks. Biomechanical stiffness, radiological densities, and bone ECM accumulation were significantly enhanced at six weeks.Reference Weinand, Gupta, Weinberg, Madisch, Neville, Jupiter and Vacanti36
Ectopic versus orthotopic environment
Many bone regeneration studies have been conducted in an ectopic environment by subcutaneous implantation in the dorsal region. Whereas ectopic implantation is appropriate for initial screening, an orthotopic environment is preferable or is required to ascertain bone repair. Femoral and calvarial defects are common models for bone repair studies using bioprinting strategies.Reference Tarafder, Davies, Bandyopadhyay and Bose25,Reference Inzana, Olvera, Fuller, Kelly, Graeve, Schwarz, Kates and Awad31 Bioprinting technology was attempted for repairing bone defects in mouse calvaria. Nano-HA was printed to repair bone defects using a 4 mm diameter trephine.Reference Keriquel, Guillemot, Arnault, Guillotin, Miraux, Amedee, Fricain and Catros37 Bone regeneration of critical-sized segmental diaphyseal defects in rabbits was allowed by long-term delivery of BMP-2 in collagen solution in printed PCL/PLGA scaffolds.Reference Shim, Kim, Park, Kundu, Kim, Kang and Cho20 Porcine calvaria defects were repaired by 3D-printed PCL scaffolds embedded with nanoporous PCL.Reference Jensen, Rolfing, Svend Le, Kristiansen, Nygaard, Hokland, Bendtsen, Kassem, Lysdahl and Bunger26
Cartilage regeneration by 3D-printed scaffolds
The joint consists of multiple tissues including articular cartilage, subchondral bone, hematopoietic marrow, and synovium (soft tissue around joints).Reference Lee, Cook, Mendelson, Moioli, Yao and Mao38 Cartilage is aneural, avascular tissue that contains few cells. Articular cartilage is a heterogeneous tissue with a composition that varies in different regions. Each zone differs in cell density, glycosaminoglycans contents, biosynthetic activity, and mechanical properties. Cells in different zones also differ in size and morphology.Reference Schuurman, Klein, Dhert, van Weeren, Hutmacher and Malda39 Three-dimensional printing for cartilage regeneration is summarized in Table II.
Three-dimensional printing for cartilage regeneration: in vivo studies.
Note: PCL, poly(caprolactone); HA, hydroxyapatite; TGF-β3, transforming growth factor beta; hBMSCs, human bone marrow mesenchymal stem cells; subQ, subcutaneous.
Biomechanical properties of 3D-printed cartilage
Three-dimensional bioprinting technology is applicable to cartilage regeneration not only due to its ability to reproduce both patient-specific grafts and complex 3D-zonal ECM architecture, but also due to its integration of properties of various biomaterials. Recently, a hybrid inkjet printing system using off-the-shelf components was reported to produce cartilage constructs with improved biological and mechanical properties. Electrospun poly(caprolactone) fibers were alternated with inkjet-printed rabbit elastic chondrocytes (mature cells) suspended in a fibrin-collagen hydrogel. The fabricated constructs formed ectopic cartilage-like tissue subcutaneously in mice with deposition of Type II collagen, which is specific to cartilage, and glycosaminoglycans, and improvement of mechanical properties over alginate or fibrin-collagen gels alone.Reference Xu, Binder, Albanna, Dice, Zhao, Yoo and Atala40 The feasibility of fabricating anatomic cartilage structures was shown by delivering chondrocytes and poly(ethylene glycol) dimethacrylate to precise target locations in 3D for mimicking different zones of articular cartilage. The interface failure strength was enhanced as assessed by push-out testing.Reference Cui, Breitenkamp, Finn, Lotz and D’Lima41 However, integration of cartilage grafts with surrounding native articular cartilage in long-term preclinical or clinical studies remains a challenge, regardless of the use of 3D-printed scaffolds or non-3D-printed scaffolds.
Cell delivery in 3D-printed scaffolds for cartilage regeneration
Ectopic tissue formation in anatomically-shaped human tibial condyle scaffolds were seeded with human bone marrow mesenchymal stem/stromal cells.Reference Cui, Breitenkamp, Finn, Lotz and D’Lima41 A composite of poly-ε-caprolactone and HA was fabricated and seeded with human bone marrow stem cells (hMSCs) with or without osteogenic differentiation. A 1 mm overlaying layer of poly(ethylene glycol)-based hydrogel encapsulating hMSCs or hMSC-derived chondrocytes was molded into anatomic shape. After six weeks of subcutaneous implantation in athymic rats, hMSCs generated substantially more angiogenesis, whereas the hMSC-derived progenies yielded more mineralized tissue in microchannels and glycosaminoglycan matrix in the cartilage-like layer.Reference Lee, Marion, Hollister and Mao42 Recently, Fedorovich et al. fabricated cell-laden, heterogeneous alginate hydrogel scaffolds of varying porosity and elastic modulus by the 3D fiber deposition technique, and encapsulated human chondrocytes and osteogenic progenitors in alginate hydrogel to yield centimeter-scale intricate hydrogel scaffolds with high cell viability with different parts.Reference Fedorovich, Schuurman, Wijnberg, Prins, van Weeren, Malda, Alblas and Dhert43 The structured tissues formed distinctive osteochondral regions indicated by collagen Types I, II, and VI after subcutaneous implantation in immunodeficient mice for six weeks.Reference Fedorovich, Schuurman, Wijnberg, Prins, van Weeren, Malda, Alblas and Dhert43
Cell homing approach for cartilage regeneration
Recruitment of endogenous cells by delivery of growth factor is an alternative to tissue regeneration by cell transplantation.Reference Mao, Stosich, Moioli, Lee, Fu, Bastian, Eisig, Zemnick, Ascherman, Wu, Rohde and Ahn32 We fabricated an anatomically correct bioscaffold by layer-by-layer bioprinting to replace the humeral head of the rabbit forelimb joint, an implant with spatial delivery of transforming growth factor beta 3 (TGFβ3). At four months, the articular surface of TGFβ3-infused bioscaffolds was fully covered with hyaline (i.e., translucent) cartilage over the scaffold surface and integrated with regenerated subchondral bone that had well-defined blood vessels, and with mechanical properties similar to that of native articular cartilage. In contrast, TGFβ3-free bioscaffolds had only isolated areas of cartilage formation, whereas no cartilage formation occurred in defect-only rabbits (injury induced, but no treatment). Our findings suggest that regeneration of cartilage may benefit from recruitment of endogenous cells from spatial delivery of biological cues (without cell transplantation) in an anatomically correct scaffold.Reference Lee, Cook, Mendelson, Moioli, Yao and Mao38 Subsequently, we showed that TGFβ3 and stromal cell-derived factor 1 (SDF-1; a signaling protein) not only chemotactically recruited adipose stem/progenitor cells, bone marrow MSCs, and synovium stem cells, but also induced chondrogenesis of the recruited cells, suggesting that homing of multiple stem/progenitor cell populations may potentially serve as an alternative or adjunctive approach to cell transplantation for cartilage in clinical applications.Reference Mendelson, Frank, Allred, Jones, Chen, Zhao and Mao44
Tooth regeneration by 3D printing
Regeneration of tooth and supporting structures is challenging, because a tooth is an organ with complexity that arguably is analogous to those of major internal organs.Reference Kim, Lee, Kim and Mao45 The bioprinting technique is especially beneficial for tooth regeneration because of its accurate control of scaffold architecture and integration of scaffold and native tissue interfaces. Three-dimensional printing studies for tooth regeneration are summarized in Table III.
Three-dimensional printing for tooth regeneration: in vivo studies.
Note: PCL, poly(caprolactone); PGA, polyglycolic acid; HA, hydroxyapatite; PDLCs, periodontal ligament cells; hDPSCs, human dental pulp stem cells; subQ, subcutaneous; BMP-7, bone morphogenetic protein 7; SDF-1, stromal-derived factor 1.
Regeneration of tooth root
Three-dimensional layer-by-layer printing was used to fabricate anatomically correct rat molar and incisor scaffolds from a hybrid of PCL and HA. These were implanted orthotopically (i.e., in a natural position) following mandibular incisor extraction and ectopically (i.e., in an abnormal position) into the dorsum with delivery of SDF-1 and bone morphogenetic protein 7 (BMP-7). Regeneration of tooth-like structures and periodontal integration by cell homing was observed after nine weeks.Reference Kim, Lee, Kim and Mao45 In another study, dental-pulp tissue was regenerated by recruitment of cell homing upon in vivo implantation by delivery of a series of cues including FGF, VEGF, PDGF, nerve growth factor, and BMP-7.Reference Kim, Xin, Moioli, Chung, Lee, Chen, Fu, Koch and Mao46
Regeneration of tooth-supporting complex by 3D bioprinting
Tooth-supporting periodontium consists of multiple tissues, including cementum, periodontal ligament (PDL), and alveolar bone. Park et al. followed a protocol to facilitate the regeneration of tooth dentin-ligament-bone complexes in vivo by controlling the multicompartmental scaffold architecture by rapid prototyping, manufacturing by 3D printing, surgical implanting into the periodontal defect site, and evaluating dual-architecture scaffolds as well as newly regenerated tissue physiology for clinical implementation. They observed newly formed cementum-like tissue, PDL, and bone structures.Reference Park, Rios, Jin, Bland, Flanagan, Hollister and Giannobile47,Reference Park, Rios, Taut, Padial-Molina, Flanagan, Pilipchuk, Hollister and Giannobile48
Multiphase periodontium tissue was recently developed by spatiotemporal delivery of multiple proteins and multiphase microstructure of poly(carprolactione)-hydroxylapatite. The scaffolds were fabricated using 3D printing seamlessly in three phases with amelogenin, connective tissue growth factor, and BMP-2 spatially delivered, and time-released in different phases. The complex structure formed PDL-like collagen I-rich fibers, mineralized tissues, and dentin/cementum-like tissues both in in vitro culture and in vivo implantation. This indicated that the optimal combination of microstructure and bioactive cues with target cell types is beneficial for periodontal tissue regeneration.Reference Lee, Hajibandeh, Suzuki, Fan, Shang and Mao49
Skin regeneration by 3D printing
Skin is the largest human organ with protective, immunologic, and sensory functions.Reference Groeber, Holeiter, Hampel, Hinderer and Schenke-Layland50 In skin injuries, autograft, allograft, wound dressing, and tissue-engineered substitutes are the current treatment choices.Reference Groeber, Holeiter, Hampel, Hinderer and Schenke-Layland50 Unlike traditional TE strategies, 3D bioprinting takes into account subtle cell–cell as well as cell–matrix interactions and precise cell layer positioning. In addition to live cells, soluble molecules and phase changing hydrogels can also be dispended in 3D-printed skin grafts.
In vitro bioprinted skin grafts
Lee et al. developed a skin biofabrication method using a 3D bioprinter with different dispensers independently operated by electromechanical valves and mounted on three axis robotic stages. Varied volume of the dispensed droplet, the liquid material, was controlled by differing the gate opening phase of the valves and the air pressure, so that it was possible to construct biomimetic skin by printing keratinocytes and fibroblasts in a layer-by-layer manner.Reference Lee, Debasitis, Lee, Lee, Fischer, Edminster, Park and Yoo51 The constructs were printed into a planar tissue culture dish and in a poly(dimethylsiloxane) mold containing 3D surface contours as a wound model. Three-dimensional bioprinted skin showed similar morphology to native skin layers prior to in vivo implantation.Reference Lee, Singh, Trasatti, Bjornsson, Xu, Tran, Yoo, Dai and Karande52 Koch et al. fabricated 3D skin grafts through deposition of fibroblasts and keratinocytes embedded in collagen, using a laser-assisted bioprinting technique, with formation of the basement membrane and intercellular junctions.Reference Koch, Deiwick, Schlie, Michael, Gruene, Coger, Zychlinski, Schambach, Reimers, Vogt and Chichkov53
Skin bioprinting for wound healing
Skin grafts by 3D printing may promote skin wound healing and restore the barrier function.Reference Orgill54–Reference MacNeil56 Three-dimensional printing studies for skin regeneration are summarized in Table IV. One study used Matriderm, a clinically approved 3D bovine collagen-elastin matrix, microinjected with cells inside the matrix.Reference Killat, Reimers, Choi, Jahn, Vogt and Radtke57 This dermal substitute was applied in a rodent full-thickness wound model. Cells appear to migrate from the transplantation site into deeper, distant layers.Reference Skardal, Mack, Kapetanovic, Atala, Jackson, Yoo and Soker58 Amniotic fluid-derived stem cells showed greater microvessel density and capillary diameters than bone marrow MSCs and showed some efficacy in wounds and burns.Reference Skardal, Mack, Kapetanovic, Atala, Jackson, Yoo and Soker58 Michael et al. showed the successful 3D printing of a cell construct and the subsequent tissue formation in full-thickness skin wounds in vivo with printed keratinocytes forming a multilayered epidermis.Reference Michael, Sorg, Peck, Koch, Deiwick, Chichkov, Vogt and Reimers59 A portable inkjet delivery system for the in situ printing of skin cells into the lesion site was developed with capacity to print human keratinocytes and fibroblasts into full-thickness skin lesions of mice.Reference Xu, Binder, Aboushwareb, Dice, Atala and Yoo60 Results show complete wound closure in three weeks.
Three-dimensional printing for skin regeneration: in vivo studies.
Note: BMSCs, bone marrow mesenchymal stem cells.
A remaining substantial challenge in 3D skin printing is whether 3D-printed skin grafts, frequently printed with cells, necessarily have an advantage over non-3D-printed skin grafts including decellularized matrices and/or biodegradable materials. Non-3D-printed skin grafts have shown some efficacy in dermal wounds including dermis deep burn woundsReference Burke, Yannas, Quinby, Bondoc and Jung61,Reference Yannas, Burke, Orgill and Skrabut62 and have the distinct advantage of the absence of the need for cell seeding. Can 3D-printed cell-laden skin scaffolds or 3D-printed cell-free scaffolds outperform non-3D-printed native matrices or biomaterial scaffolds in preclinical and clinical studies of skin wounds? Unless an affirmative answer emerges from multiple well-designed studies, 3D-printed cell-laden scaffolds remain an exciting scientific exercise but without demonstrated efficacy (and safety) in dermal wound healing.
Three-dimensional printing of other tissues
Apart from potential use in the regeneration of bone, cartilage, tooth, and skin, 3D printing technology has also been explored for the regeneration of other tissues, including nerves, tendon, trachea, adipose tissue, and cardiac tissue (Table V). A multilayered microfluidic system was developed to produce patterned hydrogel microfibers for guiding linear intercellular network formation and mimicking broad nerve bundles in vivo.Reference Kitagawa, Naganuma, Yajima, Yamada and Seki63 For anterior cruciate ligament (ACL in the knee) reconstruction, a novel silk/TCP/poly(etheretherketone) (PEEK) scaffold was 3D printed to mimic the human patellar bone-tendon-bone autograft, providing an osteoinductive element within the bone tunnel.Reference Li, He, Bian, Li, Li and Snedeker64 In addition, vascularized adipose tissue was generated in vivo by adipocyte (i.e., lipocytes)/hydrogel microspheres fabricated by a noncontact microfabrication device.Reference Yao, Zhang, Lin and Luan65 After four weeks in an in vitro culture and then injected subcutaneously into nude mice, the regenerated vasculature showed functional anastomosis with host blood vessels.
Three-dimensional printing for regeneration of other tissues: in vivo studies.
Note: TCP, tricalcium phosphate; PCL, poly(caprolactone); BMSCs, bone marrow mesenchymal stem cells; PEEK, poly(etheretherketone); HUVECs, human umbilical vein endothelial cell; hBMSCs, human bone marrow mesenchymal stem cells; PC12, cell line derived from an adrenal gland tumor in rats.
The use of 3D ECM scaffolds, obtained by the decellularization of allogeneic (from the same species) or xenogeneic (from a different species) whole organs or tissues, is a promising approach for the replacement of complex tissues and whole organs. However, it remains difficult to identify optimal cell sources, effective decellularization methods, and appropriate patient population.Reference Badylak, Weiss, Caplan and Macchiarini2 A 3D-printed scaffold was used for tracheal reconstruction in an in vivo tracheal defect model.Reference Park, Jung, Kang, Joo, Lee and Cho66,Reference Chang, Park, Park, Choi, Kim, Shin and Kim67 The replaced 3D poly(caprolactone) trachea integrated with the adjacent trachea tissue and allowed basic respiratory functions.Reference Chang, Park, Park, Choi, Kim, Shin and Kim67
For cardiac regeneration, human umbilical vascular endothelial cells and MSC were seeded in a defined pattern on a polyester-urethane-urea cardiac patch fabricated by the laser induced forward transfer cell printing technique, a direct-writing deposition technique based on pulsed laser interaction. The patches were transplanted to the infarcted zone of rat hearts after ligation,Reference Gaebel, Ma, Liu, Guan, Koch, Klopsch, Gruene, Toelk, Wang, Mark, Wang, Chichkov, Li and Steinhoff68 leading to increased vessel formation, capillary density, and integration of human cells into the functionally connected vessels of the murine vascular system.Reference Gaebel, Ma, Liu, Guan, Koch, Klopsch, Gruene, Toelk, Wang, Mark, Wang, Chichkov, Li and Steinhoff68 The fabrication of microchannels in an alginate scaffold using a CO2 laser engraving system also promoted vessel-like networks and increased cell penetration and vessel density after subcutaneous implantation in mice.Reference Zieber, Or, Ruvinov and Cohen69 Inkjet-printed scaffolds with human amniotic fluid-derived stem cells, canine smooth muscle cells, and bovine aortic endothelial cells survived and matured into tissues with vascularization when implanted subcutaneously into athymic nude mice for up to 18 weeks.Reference Xu, Zhao, Zhu, Albanna, Yoo and Atala70
Future directions
Bioprinting has shown great promise in tissue regeneration and relevance to eventual applications of 3D-printed organs scaffolds. Multiple challenges need to be overcome for broad applications of organ bioprinting.
Biologic issues
Some of the biological issues that need to be addressed for clinical application of 3D printing include oxygen diffusion, cell perfusion, cell migration, and guided tissue differentiation. Cell survival and vascularization within the printed structures appear to be central issues. Oxygen, nutrients, and metabolic waste products are transported via a microvascular and an interstitial network that are connected to the macrocirculation.Reference Choi, Kim, Kwon, Che, Lee, Cho, Kang, Ra and Kang71–Reference Seliktar, Dikovsky and Napadensky73 Angiogenesis can be promoted by pre-seeding printed scaffolds with mature or precursor endothelial cells or by the incorporation of angiogenic growth factors. Additionally, scaffolds can be designed to have pore size, porosity, and pore size distribution that favor vascular sprouting. Furthermore, microsurgical procedures that promote host anastomosis (blood vessel interconnections) are also effective.Reference Novosel, Kleinhans and Kluger74
Engineering issues
Engineering challenges include the efficiency, reproducibility, practicality, and biocompatibility of bioprinting processes. Further progress is needed in pre-processing, processing, and post-processing. For pre-processing and processing, efforts are being focused on conceptual and theoretical development in a basic science and engineering framework, increasingly practical and reliable printing methods and other deposition devices, more sophisticated, intelligent hydrogels, bioinks, and biomaterials.Reference Mironov, Reis and Derby75 For post-processing, accelerated tissue maturation technologies are being developed by either shortening in vitro culture time after cells are encapsulated in hydrogels or by developing techniques by transplant printed tissues directly in vivo, as nature is considered to be the best bioreactor.Reference Dababneh and Ibrahim76
Costs
Bioprinting is a novel tissue fabrication approach. The economic feasibility of the technique needs to be overcome before bioprinting can become a common and sustainable treatment intervention. The cost of transplanting bioprinted organs involved in the pre- and post-operations and other medical treatments on the transplant list could potentially at least match those of current transplant methods once bioprinting organs becomes clinically feasible. There is room to develop enabling technologies until the economic costs of bioprinting reach a level of feasibility.
Regulatory and safety issues
As a new topic of study, safety guidelines have not been firmly established in this field. The side effects of bioprinting have rarely been addressed, including questions such as biomaterials degradation and tissue integration, biocompatibility, and continuous tissue synthesis during material degradation. Certain standards must be established in order to guarantee the safety and reproducibility of 3D-printed organ scaffolds.
Conclusion
Three-dimensional bioprinting offers a potential solution for current organ shortage and tissue loss. With the capacity for unprecedented resolution and versatility, 3D printing can yield patient-specific, defect-specific, or generic organ scaffolds at any scalable size. Current bioprinters can deposit not only biomaterials, but also cells and/or signaling molecules. This article has focused on in vivo applications of 3D bioprinting in tissue and organ regeneration, rather than technology development in 3D printing.
Initial progress has been made in applications of 3D printing in bone, cartilage, teeth, and skin, as well as several other tissues such as blood vessels and tracheas. Practice of 3D printing technologies in musculoskeletal and dermal/dental tissues and organs has generated proof of concept data that likely will benefit 3D printing for internal organs. There are a small number of clinical case reports on the use of 3D-printed scaffolds in isolated patients. The initial enthusiasm of 3D printing in generating organ scaffolds as donor organs needs to be matched with in-depth understanding of cellular behavior including directed differentiation, chemotaxis, ECM production, and maintenance of stem cell niche (promoting stem cell residence in a supportive environment) once 3D-printed organ scaffolds are applied in the host. The dazzling capacity of 3D bioprinting needs to be translated into practice in preclinical studies, which are frequently required by regulatory agencies prior to clinical trials.
Acknowledgments
We thank R. Burdie, Q. Guo, and J. Melendez for administrative and technical assistance. The effort for composition of this article is supported by NIH grants R01AR065023 and R01DE023112.